Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Slugger who wrote (14105)	7/12/2000 9:35:43 PM
From: Robert K.	Read Replies (1) \| Respond to of 17367

I find it a bit humorus that the big shots on cnbc are playing up anti cd11a, and the real xoma investors are still all fired up over bpi. Hmmmmmm. also, cacaito>i couldnt believe that recent note was yours. you actually,tentatively gave bpi some credit. I am not asking for rah,rah notes, but that was a lot more reasonable tone. There is hope for you yet. btw-i liked the note every though i may not agree with it some. also,> i dont meant to play down anti-cd, imo its got a great shot and a huge market. also,>i have been wondering about the lbp dummy also>I am considering another "interesting" post from my "interesting post" archive.

To: Slugger who wrote (14105)	7/12/2000 9:59:10 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Slugger, IMO selling half your position was a bad move. Sometimes it is a very hard to sell the remaining odd lot. Just kidding, you are a good guy and I watch your post with appreciation. So thanks for the past post, hope you will not now make just half as many.

To: Slugger who wrote (14105)	7/12/2000 10:28:41 PM
From: StockDoc	Read Replies (3) \| Respond to of 17367

Thanks, interesting patent application. One of the most interesting thing is the attempt to blur protein C and activated protein C. They are used as if they were "identical". It is as if one would call both a piece of raw flesh and a New York steak a meal. APC is an anticoagulant, protein C is not. I still don't see the invention (discovery) in this application. Combination of medical modalities aimed at different pathogenic factors in a complex syndrome is a necessary and obvious medical routine. Next time LLY might try to patent (a)PC plus antibiotics, (a)PC plus saline infusion, APC plus oxygen, APC plus bed rest, APC plus Tylenol, or APC plus medical care. These are all original combinations.